MRI features that predict progression of residual disease after ablation of extra-abdominal desmoid fibromatosis
European Radiology · 21.01.2025 · 35 (7) · 4161-4170
DOI: 10.1007/s00330-024-11319-w ↗Kurz gefasst
Fachartikel in der Zeitschrift European Radiology, online erschienen am 21.01.2025. Verfasst von Daniel M Düx und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Hannover Medical School (MHH), Carl-Neuberg-Straße 1, 30625, Hannover, Germany. duex.daniel@mh-hannover.de. Hauptthemen laut MEDLINE: Desmoid Tumors, Magnetic Resonance Imaging, Ablation Techniques. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Focused Ultrasound Foundation.
Abstract (Originalsprache)
Objective
To identify MRI features of desmoid tumors (DTs) that predict the growth of residual disease following ablation.
Methods
Patients who underwent MRI-guided ablation for DTs between February 2013 and April 2021 were included in this single-center IRB-approved retrospective study. MRI scans assessed three suspicious tissue features: intermediate T2 signal [+iT2], nodular appearance [+NOD], and contrast enhancement [+ENH]. Percent-monthly change in diameter (PMCD) of suspicious foci determined growth (PMCD > 1%), unchanged (PMCD between −1% and +1%), or regression (PMCD < −1%). Statistical tests compared mean PMCD between groups and evaluated sensitivity and specificity.
Results
Thirty-three patients (32 years ± 13.3; 22 females) with 34 DTs underwent 47 MRI-guided ablations, with a median follow-up of 269 days (IQR 147). Of 93 suspicious foci, 62 (67%) grew (PMCD: +5.6% IQR: 5.8), 13 (14%) remained unchanged (PMCD: −0.1% IQR: 0.6), and 18 (19%) regressed (PMCD: −3.9% IQR: 4.2). Features [+iT2], [+ENH], and [+NOD] were associated with PMCDs of +5.2% IQR: 6.0, +3.4% IQR: 6.0, and +3.4% IQR: 6.5, respectively, compared to −1.5% IQR: 4.7 ( p < 0.0001), −0.5% IQR: 0.8 ( p = 0.003), and +0.4% IQR: 7.5 ( p = 0.0056) for their respective negative counterparts. Sensitivity, specificity, and accuracy for distinguishing growth were [+iT2]: 0.95, 0.71, 0.87, [+ENH]: 1.00, 0.32, 0.77, and [+NOD]: 0.84, 0.42, 0.70. Combining [+iT2 + NOD + ENH] yielded PMCD +5.9% IQR: 6.2 and the best performance for distinguishing growth (sensitivity 0.81, specificity 0.94, accuracy 0.85).
Discussion
MRI features reliably predict the growth of residual or recurrent DTs post-ablation, with [+iT2] being the most accurate. Adding nodular enhancement to [+iT2] improved specificity without sacrificing accuracy. Key Points Question Post-ablation imaging of desmoids is challenging due to tumor heterogeneity and treatment-related inflammation. This study evaluates MRI features for assessing future tumor growth.
Findings
Foci of intermediate T2 signal post-ablation predicted desmoid growth with high sensitivity (0.95), while T2 signal, nodularity, and enhancement combined offer high specificity (0.94). Clinical relevance Intermediate T2 signal predicts desmoid tumor growth post-ablation with high sensitivity and accuracy but moderate specificity. Combining nodularity and enhancement improves specificity and predictive value, helping clinicians in managing desmoid tumor patients post-ablation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Hannover Medical School (MHH), Carl-Neuberg-Straße 1, 30625, Hannover, Germany. duex.daniel@mh-hannover.de.
- Department of Radiology, Stanford School of Medicine, Stanford, CA, 94305, USA.
Förderung
- Focused Ultrasound Foundation
Zitieren
APA
Düx, D. M., Chodakiewitz, Y., Bitton, R., Sewell, S., Sheth, V. R., Ghanouni, P., & Brunsing, R. L. (2025). MRI features that predict progression of residual disease after ablation of extra-abdominal desmoid fibromatosis. European Radiology, 35(7), 4161-4170. https://doi.org/10.1007/s00330-024-11319-w
Vancouver
Düx DM, Chodakiewitz Y, Bitton R, Sewell S, Sheth VR, Ghanouni P, et al. MRI features that predict progression of residual disease after ablation of extra-abdominal desmoid fibromatosis. European Radiology. 2025;35(7):4161-4170. doi:10.1007/s00330-024-11319-w
BibTeX
@article{Dx2025,
author = {Düx, Daniel M and Chodakiewitz, Yosef and Bitton, Rachelle and Sewell, Sharmila and Sheth, Vipul R and Ghanouni, Pejman and Brunsing, Ryan L},
title = {MRI features that predict progression of residual disease after ablation of extra-abdominal desmoid fibromatosis},
journal = {European Radiology},
year = {2025},
volume = {35},
number = {7},
pages = {4161--4170},
doi = {10.1007/s00330-024-11319-w}
}
EUVIMED